Article Details
Retrieved on: 2024-05-11 20:00:03
Tags for this article:
Click the tags to see associated articles and topics
Summary
Azitra, Inc. announced preclinical data showing ATR-12's potential as a topical treatment for Netherton syndrome by delivering LEKTI protein and reducing IL-36γ, a pro-inflammatory cytokine. The treatment was also safe in minipigs.
Article found on: pipelinereview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here